Market Research Reports and Industry Reports

RIKEN - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Summary

RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, laboratories and research facilities collaborate and support each other to enhance the outcomes. The organizations research spans the entire range of natural sciences, from developmental biology and neuroscience to quantum physics, computer science and green innovation. It also enters into external collaboration and works in partnership with private companies to transform its scientific developments into commercial products. The organization operates through facilities in Wako, Tsukuba, Yokohama, Kobe and Harima. RIKEN is headquartered in Wako, Saitama, Japan.

RIKEN - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RIKEN, Medical Devices Deals, 2011 to YTD 2017 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RIKEN, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 14
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 15
RIKEN Brain Science Enters Into Research Collaboration With Astellas Pharma 16
Licensing Agreements 17
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN - Key Competitors 19
RIKEN - Key Employees 20
RIKEN - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Government and Public Interest 23
Jan 20, 2016: Study results leading to the development of a new type of anticancer agent 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


RIKEN, Pharmaceuticals & Healthcare, Key Facts 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RIKEN, Deals By Therapy Area, 2011 to YTD 2017 8
RIKEN, Medical Devices Deals, 2011 to YTD 2017 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 14
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 15
RIKEN Brain Science Enters Into Research Collaboration With Astellas Pharma 16
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN, Key Competitors 19
RIKEN, Key Employees 20
RIKEN, Subsidiaries 21

List Of Figures


RIKEN, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RIKEN, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RIKEN, Medical Devices Deals, 2011 to YTD 2017 9

RIKEN - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and

USD 250View Report

Reemtsma Cigarettenfabriken GmbH in Tobacco (Germany)

With its broad product portfolio in tobacco, Reemtsma follows a conservative strategy. The company is being cautious with regard to investment in vapour products due to the high development costs

USD 150View Report

Asaka Riken Co Ltd Strategic Analysis Review- Asaka Riken Co Ltd SWOT, Outlook, Operations and Financial Profile

Asaka Riken Co Ltd Company Profile provides strategic analysis of Asaka Riken Co Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200View Report

InDex Pharmaceuticals Holding AB (INDEX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct, which is in clinical development for the

USD 250View Report

Steris Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Steris Corp (Steris), formerly Innovative Medical Technologies is a subsidiary of Steris Plc is a healthcare services provider that offers infection prevention and contamination control products, and surgical and critical

USD 250View Report

University Hospital of Lyon - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University Hospital of Lyon (HCL) is a healthcare service provider that offers patient care and educational services. The hospital provides care, education, research and medical innovation, prevention and health training

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :24
Country :Japan
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop